In September 2018 the World Health Organization announced a new effort, the WHO GLOBAL INITIATIVE FOR CHILDHOOD CANCER, with the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives. This new target represents a doubling of the global cure rate for children with cancer.
The aims of the Initiative are two-fold: to increase prioritization of childhood cancer through awareness raising at global and national levels and to expand the capacity of countries to deliver best practice in childhood cancer care. Concretely, WHO will support governments to assess current capacities in cancer diagnosis and treatment including the availability of medicines and technologies, set and cost priority cancer diagnosis and treatment programs, and integrate childhood cancer into national strategies, health benefits packages and social insurance schemes.
Cancer is a leading cause of death for children, with 300,000 new cases diagnosed each year among children aged 0-19 years. Children with cancer in low and middle-income countries are 4 times more likely to die of the disease than children in high-income countries. This is because their illnesses are not diagnosed, they are often forced to abandon treatment due to high costs, and the health professionals entrusted with their care lack specialized training.
The Initiative, which involves development of a WHO technical package to help scale-up capacities within national health systems, will be achieved with support from a host of partners.
“Too many children have their lives cut short by cancer, and survival rates in poor countries are scandalously lower than those in wealthy countries,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
At the Institute of Interventional Oncology (IDOI México), our medical team has more than 25 years of professional experience. Based on results and the obtained experience, IDOI started a research on different procedures, which are personalized, often complex and minimally invasive modalities.